Which type of leukemia can be successfully treated by chemotherapy resulting in suppression, but not complete remission?
Acute lymphoblastic leukemia (ALL).
Chronic lymphocytic leukemia (CLL).
Acute myelogenous leukemia (AML).
Hairy-cell leukemia.
The Correct Answer is B
Choice A reason: Acute lymphoblastic leukemia (ALL) is an aggressive malignancy of lymphoid cells, often achieving complete remission with intensive chemotherapy, especially in children. Suppression without remission is not typical, as ALL responds well to treatment, targeting rapidly dividing blast cells. CLL, a slower-progressing disease, better fits the description of suppression without complete cure.
Choice B reason: Chronic lymphocytic leukemia (CLL) is a low-grade malignancy of mature B-lymphocytes, often managed with chemotherapy to suppress disease progression rather than achieve complete remission. CLL’s indolent nature means it can be controlled, but residual disease persists due to slow cell turnover, aligning with the question’s description of suppression.
Choice C reason: Acute myelogenous leukemia (AML) is an aggressive malignancy of myeloid cells, requiring intensive chemotherapy or stem cell transplant for potential remission. Suppression without remission is less common, as AML treatment aims for complete response. CLL’s chronic nature makes it more likely to result in disease control rather than cure.
Choice D reason: Hairy-cell leukemia is a rare, indolent B-cell malignancy highly responsive to purine analogs, often achieving long-term remission or near-cure. Suppression without remission is not characteristic, as treatment typically yields durable responses. CLL’s partial response to chemotherapy better matches the scenario of ongoing disease suppression.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
Choice A reason: Bone reabsorption exceeding formation describes osteoporosis, not rheumatoid arthritis. RA involves autoimmune inflammation of synovial joints, driven by cytokines and T-cells, not primary bone fragility. This choice is incorrect, as it misrepresents RA’s immune-mediated synovial pathology with a bone density disorder.
Choice B reason: Repetitive stress may cause osteoarthritis, not RA. RA is an autoimmune condition where T-cells and cytokines attack synovium, causing inflammation and cartilage damage. Stress may exacerbate symptoms, but it is not the primary mechanism, making this incorrect for RA’s pathophysiological explanation.
Choice C reason: RA’s pathophysiology involves T-cells producing cytokines (e.g., TNF-α) and antigen-antibody reactions, triggering synovial inflammation. This autoimmune process causes wrist swelling and joint damage, as seen in the client. This mechanism accurately explains RA’s inflammatory nature, per rheumatology evidence, and is appropriate for client education.
Choice D reason: Uric acid imbalance and urate crystal deposition cause gout, not RA. RA is driven by autoimmune T-cell and cytokine activity, not crystal-induced inflammation. This choice is incorrect, as it describes a different arthritic condition unrelated to the client’s autoimmune rheumatoid arthritis pathology.
Correct Answer is B
Explanation
Choice A reason: Macrophages, lymph, and cytokines are part of the innate immune response, acting after pathogens breach initial barriers. First-line defenses are physical and chemical barriers like mucosa and secretions, not immune cells or fluids. This choice represents secondary defenses, making it incorrect for the primary barrier role.
Choice B reason: Lung epithelium, gastric mucosa, and tears are first-line defenses, preventing pathogen entry. Lung cilia trap microbes, gastric acid kills bacteria, and tears’ lysozymes neutralize pathogens. These physical and chemical barriers form the body’s initial protection, aligning with immunology principles for primary defense against infection.
Choice C reason: Interferon, T cells, and neutrophils are part of adaptive and innate immunity, activated after pathogen penetration. First-line defenses involve barriers like mucosa, not immune mediators or cells. This choice describes secondary immune responses, making it incorrect for the initial protective structures in humans.
Choice D reason: Thymus, bone marrow, and pancreas are involved in immune cell production and metabolism, not direct pathogen defense. First-line defenses are external barriers like lung epithelium or tears. These internal organs support immunity but are not primary barriers, making this incorrect for first-line defense structures.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
